Dieter Moosmayer

This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft, Biontech Ag. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Moosmayer. Retrieved from https://idiyas.com/inventor/dieter-moosmayer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 9)

% Patents Active = 87.5

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 26(Granted Patents)

Company Filing History:

6 out of 387

Bayer Pharma Aktiengesellschaft

patents

2 out of 12,268

Bayer Aktiengesellschaft

Dana-Farber-Cancer Institute Inc.

patents

5. 1 out of 486

The Broad Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2022

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11529356 - 2-(morpholin-4-yl)-1,7-naphthyridines (2022-12-20),

2. 11339157 - 4H-pyrrolo[3,2-c]pyridin-4-one derivatives (2022-05-24),

3. 10772893 - 2-(morpholin-4-yl)-1,7-naphthyridines (2020-09-15),

4. 10722501 - Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof (2020-07-28),

5. 9993484 - 2-(morpholin-4-yl)-1,7-naphthyridines (2018-06-12),

6. 9944708 - Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines) (2018-04-17),

7. 9549932 - 2-(morpholin-4-yl)-1,7-naphthyridines (2017-01-24),

8. 8980265 - Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) (2015-03-17),

Title: The Innovative Journey of Dieter Moosmayer

Introduction: Dieter Moosmayer, a visionary inventor hailing from Berlin, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Dieter Moosmayer holds several patents in the field of renewable energy technologies, with his most recent patent focusing on a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Dieter Moosmayer has worked for leading companies such as Siemens and Bosch, where he spearheaded research and development projects that have shaped the future of sustainable energy solutions.

Collaborations: Throughout his career, Dieter Moosmayer has collaborated with top research institutions in Germany, including the Fraunhofer Society and the Max Planck Institute, to further his innovative ideas and bring them to life through cutting-edge technologies.

Conclusion: Dieter Moosmayer's relentless passion for innovation and his commitment to creating a more sustainable future have solidified his position as a pioneering inventor in the field of renewable energy technologies.

Profile summary based on public USPTO records.